Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 71839-107

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 71839-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Be Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Daptocarton (Daptocarton)

This is a package of Daptomycin for Injection containing 500mg of sterile captomycin, with no preservatives, and must be refrigerated. The package is intended to be used for intravenous infusion using 0.9% Sodium Chloride Injection for reconstitution only. The parenteral product must be inspected visually prior to administration. See enclosed package insert for specific dosage and administration instructions. The package is created by BE Pharmaceuticals Inc. and made in India.*

FDA Label Image

Daptologo (Daptologo)

FDA Label Image

Daptostr (Daptostr)

FDA Label Image

Daptoviallabel

This is a description for Daptomycin for Injection. The product comes in a single-dose vial with 500mg per vi, and it must be refrigerated between 2°C to 8°C. To reconstitute, use 10 mL of 0.9% Sodium Chloride Injection. The product is suitable for intravenous infusion, and the package insert contains complete information on dosage and administration. The unused portion should be discarded, and the product is distributed by BE Pharmaceuticals Inc., located at 203 New Edition Court, Cary, NC 27511.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.